MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$83,720,000
EPS
-$2.87
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Collaboration revenue
-
-
0
0
Research and development
69,416,000
77,987,000
77,506,000
65,797,000
General and administrative
27,488,000
27,873,000
19,538,000
12,562,000
Total operating expenses
96,904,000
105,860,000
97,044,000
78,359,000
Loss from operations
-96,904,000
-105,860,000
-97,044,000
-78,359,000
Other income, net
13,184,000
13,299,000
8,133,000
4,425,000
Total other income
13,184,000
13,299,000
8,133,000
4,425,000
Net loss
-83,720,000
-92,561,000
-88,911,000
-73,934,000
Basic EPS
-2.87
-3.2
-3.485
-3.36
Diluted EPS
-2.87
-3.2
-3.485
-3.36
Basic Average Shares
29,131,375
28,883,596
25,510,775
21,977,268
Diluted Average Shares
29,131,375
28,883,596
25,510,775
21,977,268
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Other income, net
$13,184,000
(166.88%↑ Y/Y)
Net loss
-$83,720,000
(-17.70%↓ Y/Y)
Total other income
$13,184,000
(166.88%↑ Y/Y)
Loss from operations
-$96,904,000
(-27.39%↓ Y/Y)
Total operating
expenses
$96,904,000
(27.39%↑ Y/Y)
Research and development
$69,416,000
(10.17%↑ Y/Y)
General and
administrative
$27,488,000
(110.46%↑ Y/Y)
Buy us a coffee
Praxis Precision Medicines, Inc. (PRAX)
Praxis Precision Medicines, Inc. (PRAX)